Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C) : a randomised, double-blind, placebo-controlled trial. / Johansen, Nicklas J.; Dejgaard, Thomas F.; Lund, Asger; Schluntz, Camilla; Frandsen, Christian S.; Forman, Julie L.; Albrechtsen, Nicolai J. Wewer; Holst, Jens J.; Pedersen-Bjergaard, Ulrik; Madsbad, Sten; Vilsbøll, Tina; Andersen, Henrik U.; Knop, Filip K.

I: The Lancet Diabetes & Endocrinology, Bind 8, Nr. 4, 2020, s. 313-324.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Johansen, NJ, Dejgaard, TF, Lund, A, Schluntz, C, Frandsen, CS, Forman, JL, Albrechtsen, NJW, Holst, JJ, Pedersen-Bjergaard, U, Madsbad, S, Vilsbøll, T, Andersen, HU & Knop, FK 2020, 'Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial', The Lancet Diabetes & Endocrinology, bind 8, nr. 4, s. 313-324. https://doi.org/10.1016/S2213-8587(20)30030-9

APA

Johansen, N. J., Dejgaard, T. F., Lund, A., Schluntz, C., Frandsen, C. S., Forman, J. L., ... Knop, F. K. (2020). Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology, 8(4), 313-324. https://doi.org/10.1016/S2213-8587(20)30030-9

Vancouver

Johansen NJ, Dejgaard TF, Lund A, Schluntz C, Frandsen CS, Forman JL o.a. Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2020;8(4):313-324. https://doi.org/10.1016/S2213-8587(20)30030-9

Author

Johansen, Nicklas J. ; Dejgaard, Thomas F. ; Lund, Asger ; Schluntz, Camilla ; Frandsen, Christian S. ; Forman, Julie L. ; Albrechtsen, Nicolai J. Wewer ; Holst, Jens J. ; Pedersen-Bjergaard, Ulrik ; Madsbad, Sten ; Vilsbøll, Tina ; Andersen, Henrik U. ; Knop, Filip K. / Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C) : a randomised, double-blind, placebo-controlled trial. I: The Lancet Diabetes & Endocrinology. 2020 ; Bind 8, Nr. 4. s. 313-324.

Bibtex

@article{ac533e4fcae94f4c9edbe53aef06af03,
title = "Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial",
author = "Johansen, {Nicklas J.} and Dejgaard, {Thomas F.} and Asger Lund and Camilla Schluntz and Frandsen, {Christian S.} and Forman, {Julie L.} and Albrechtsen, {Nicolai J. Wewer} and Holst, {Jens J.} and Ulrik Pedersen-Bjergaard and Sten Madsbad and Tina Vilsb{\o}ll and Andersen, {Henrik U.} and Knop, {Filip K.}",
year = "2020",
doi = "10.1016/S2213-8587(20)30030-9",
language = "English",
volume = "8",
pages = "313--324",
journal = "The Lancet Diabetes & Endocrinology",
issn = "2213-8587",
publisher = "The Lancet Publishing Group",
number = "4",

}

RIS

TY - JOUR

T1 - Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C)

T2 - a randomised, double-blind, placebo-controlled trial

AU - Johansen, Nicklas J.

AU - Dejgaard, Thomas F.

AU - Lund, Asger

AU - Schluntz, Camilla

AU - Frandsen, Christian S.

AU - Forman, Julie L.

AU - Albrechtsen, Nicolai J. Wewer

AU - Holst, Jens J.

AU - Pedersen-Bjergaard, Ulrik

AU - Madsbad, Sten

AU - Vilsbøll, Tina

AU - Andersen, Henrik U.

AU - Knop, Filip K.

PY - 2020

Y1 - 2020

U2 - 10.1016/S2213-8587(20)30030-9

DO - 10.1016/S2213-8587(20)30030-9

M3 - Journal article

VL - 8

SP - 313

EP - 324

JO - The Lancet Diabetes & Endocrinology

JF - The Lancet Diabetes & Endocrinology

SN - 2213-8587

IS - 4

ER -

ID: 239075974